Story coverage

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

Ibogaine is banned under the federal government's most restrictive category for illegal, high-risk drugs.

Trump Signs Executive Order To Allow Psychedelic Treatments

Psychedelic treatments for mental illnesses including depression will soon be available thanks to a new Executive Order signed by President Trump

Trump-backed plan could fast-track psychedelic therapies — here's what to know

President Trump has signed an executive order to fast-track psychedelic research and FDA approval, sparking debate among doctors over safety and mental health benefits.

Trump signs executive order directing FDA to review psychedelics designated as breakthrough therapy drugs

President Donald Trump signed an executive order that directs the FDA to accelerate their review of "psychedelics already designated as breakthrough therapy drugs."

Trump Signs Executive Order to Research Psychedelics, Including Ibogaine, for Mental Health Treatment

Updated on: April 18, 2026 / 11:54 AM EDT / CBS News

Trump signs order to expedite medical psychedelic drug treatment, research

President Trump signed an executive order Saturday to fast-track access to medical psychedelic drug research and treatment.